Mowi asks to trial new lice drug in Scotland Mowi Scotland has taken a first step towards the use of Benchmark’s lice medicine Ectosan in the country’s salmon farming industry.
Hatch nets The Fish Site UK-based aquaculture portal The Fish Site has been bought by Hatch Blue, which invests in, and runs accelerator programmes for, sustainable aquaculture start-ups.
Benchmark science chief steps down Aquaculture genetics, health and nutrition business Benchmark Holdings has announced the resignation of chief scientific officer and director Alex Raeber with effect from July 31.
Ova demand unaffected by Covid-19, says Benchmark Aquaculture genetics, health and advanced nutrition company Benchmark Holdings has said demand for its salmon ova has not yet been materially affected by the Covid-19 epidemic, although it anticipates earnings will be hit in other parts of the business such as shrimp nutrition.
Benchmark sea lice treatment identity revealed The sea lice treatment developed by Benchmark is the neonicotinoid insecticide imidacloprid, it has been revealed.
Benchmark gains more than it loses from ban on Norwegian ova Salmon egg supplier Benchmark Genetics has been a net winner following an ongoing ban imposed on the import of ova from Norway to Scotland last summer.
New lice treatment now in hands of regulators The arrival of a new salmon lice treatment is a step closer after its maker completed a regulatory dossier on the product as part of the process to win permission to use it.
Benchmark makes £2m loss for first quarter Aquaculture health, nutrition and genetics business Benchmark Holdings made a loss of nearly £2 million in the first quarter of its 2020 financial year, which starts in October, but said restructuring and cost savings would help it deliver on its expectations for the year.
Benchmark raises £43m from share sale Aquaculture health, nutrition and genetics business Benchmark Holdings today announced that it conditionally raised £43 million by selling shares through an open offer and a market placing.
Benchmark losses rise to £83m after tough year Aquaculture health, advanced nutrition and genetics business Benchmark Holdings has placed the launch of its new BMK08 lice treatment as a priority in 2020 after a tough year in which losses increased to £83 million from £4.4m in 2018.
Pye says goodbye to Benchmark Malcolm Pye, one of three founders of aquaculture health, advanced nutrition, and genetics business Benchmark Holdings, is to leave the company, it was announced today.
Benchmark reports good interest in services sell-off UK-based aquaculture health, nutrition and genetics company Benchmark said today that it had received “a good level of interest” for businesses in its Knowledge Services division and veterinary services.
Potted shrimp: Benchmark offers crustacean insight UK-based aquaculture health, nutrition and genetics business Benchmark was today launching a new publication offering expert insights into the key challenges and opportunities in shrimp aquaculture.
Benchmark handed £6.8m as it goes solo in Chile UK-based aquaculture health, nutrition and genetics business Benchmark Holdings today announced that it will receive US$8.75 million (£6.8m) from AquaChile as the second and final payment due following the dissolution of a short-lived joint venture with the salmon farmer.
